ZNF200 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.276200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.597990E-01
Normal-vs-Stage2
7.219800E-02
Normal-vs-Stage3
6.669900E-02
Normal-vs-Stage4
4.700000E-01
Stage1-vs-Stage2
9.329400E-01
Stage1-vs-Stage3
4.620100E-02
Stage1-vs-Stage4
3.674600E-01
Stage2-vs-Stage3
9.917500E-02
Stage2-vs-Stage4
4.171200E-01
Stage3-vs-Stage4
3.749600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.026000E-02
Normal-vs-AfricanAmerican
2.006800E-01
Normal-vs-Asian
3.941500E-02
Caucasian-vs-AfricanAmerican
8.546800E-01
Caucasian-vs-Asian
1.682780E-01
AfricanAmerican-vs-Asian
4.621400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.928300E-02
Normal-vs-Female
3.498200E-02
Male-vs-Female
7.567400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.570200E-01
Normal-vs-Age(41-60Yrs)
8.194200E-02
Normal-vs-Age(61-80Yrs)
6.419600E-02
Normal-vs-Age(81-100Yrs)
2.772000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.628800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.102200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.825200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.008600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.520600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.678600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.838400E-02
Normal-vs-Daily Drinker
3.698000E-02
Normal-vs-Weekly Drinker
2.471600E-01
Normal-vs-Occasional Drinker
4.189600E-01
Normal-vs-Social Drinker
1.678010E-01
Non Drinker-vs-Daily Drinker
8.511400E-01
Non Drinker-vs-Weekly Drinker
2.873800E-01
Non Drinker-vs-Occasional Drinker
5.929800E-02
Non Drinker-vs-Social Drinker
1.094370E-01
Daily Drinker-vs-Weekly Drinker
2.740800E-01
Daily Drinker-vs-Occasional Drinker
5.497900E-02
Daily Drinker-vs-Social Drinker
1.050990E-01
Weekly Drinker-vs-Occasional Drinker
7.582800E-01
Weekly Drinker-vs-Social Drinker
7.935600E-01
Occasional Drinker-vs-Social Drinker
9.708000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.693200E-01
Normal-vs-Grade 2
1.068180E-01
Normal-vs-Grade 3
8.899700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.770800E-01
Grade 1-vs-Grade 3
1.430440E-01
Grade 1-vs-Grade 4
2.693200E-01
Grade 2-vs-Grade 3
3.104000E-01
Grade 2-vs-Grade 4
1.068180E-01
Grade 3-vs-Grade 4
8.899700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.901700E-02
Normal-vs-NonDiabetic
4.918000E-02
Diabetic-vs-NonDiabetic
4.827800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.099640E-01
Normal-vs-NoPancreatitis
4.984200E-02
Pancreatitis-vs-NoPancreatitis
3.762600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.885800E-02
Normal-vs-N1
8.145800E-02
N0-vs-N1
3.567800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.296300E-02
Normal-vs-TP53-NonMutant
1.258770E-01
TP53-Mutant-vs-TP53-NonMutant
7.940800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
